• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEART VALVES SANTA ANA CONTEGRA; CONDUIT,VALVED,PULMONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEART VALVES SANTA ANA CONTEGRA; CONDUIT,VALVED,PULMONIC Back to Search Results
Model Number 200
Device Problems Calcified (1077); Gradient Increase (1270); Device Operates Differently Than Expected (2913)
Patient Problems Pulmonary Regurgitation (2023); Pulmonary Valve Stenosis (2024); Cusp Tear (2656)
Event Date 12/30/2013
Event Type  Injury  
Manufacturer Narrative
The device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.At this time, a conclusion to the reported endocarditis three yrs post implant is not determined.Endocarditis that occurs more than 12 month after the procedure are called late prosthetic-valve endocarditis and are largely community-acquired versus a result of the manufacturing process of the valve.It is possible that the reported endocarditis contributed to the clinical observations 5 yrs post implant.The device was explanted and another contegra was implanted.The device was not returned for analysis.(b)(6).
 
Event Description
Medtronic received information that five years post implant of the pulmonary valved conduit was explanted due to stenosis, calcification, cuspal tears, and central regurgitation with a peak gradient of 59mmhg and a mean gradient of 32mmhg.Operative notes indicated patient with a history of possible endocarditis three years post implant.The conduit was removed in pieces and will not be returned.Another contegra was implanted.No further adverse patient effects were reported.
 
Manufacturer Narrative
Product analysis: without the return of the product, no definitive conclusion can be made regarding the clinical observation.Conclusion: the device history record review is in process, once the review is complete a supplemental report will be submitted.(b)(4).(b)(6).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTEGRA
Type of Device
CONDUIT,VALVED,PULMONIC
Manufacturer (Section D)
HEART VALVES SANTA ANA
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
mike gaffney
8200 coral sea street ne
mounds view, MN 55112
7635265629
MDR Report Key3603629
MDR Text Key11626923
Report Number2025587-2014-00013
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative,company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/03/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/03/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/18/2010
Device Model Number200
Device Catalogue Number200H16
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/03/2014
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/18/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00006 YR
-
-